Dual blockade of CD47 and CD24 signaling using a novel bispecific antibody fusion protein enhances macrophage immunotherapyYun Yang, Tianyun Wang, He Wu et al.|Molecular Therapy — Oncolytics|2023Cited by 39
Therapeutic efficacy of an anti-PD-L1 antibody based immunocytokine in a metastatic mouse model of colorectal cancerXi Chen, Hao Wang, Sheng Hou et al.|Biochemical and Biophysical Research Communications|2016Cited by 18
Development of a reliable cell-based reporter gene assay to measure the bioactivity of anti-HER2 therapeutic antibodiesXiang Zhao, Fugui Wang, Weizhu Qian et al.|Journal of Pharmaceutical and Biomedical Analysis|2024Cited by 5
Improving product quality and productivity of an antibody-based biotherapeutic using inverted frustoconical shaking bioreactorsXuekun Wang, Huaizu Guo, Jin Xu et al.|Frontiers in Bioengineering and Biotechnology|2024Cited by 3
Highly drug/target-tolerant neutralizing antibody (NAb) assay development through target-based drug depletion and drug-based NAb extraction for an anti-EGFR therapeutic monoclonal antibodyRongrong Fu, Jin Xu, Qingcheng Guo et al.|Journal of Pharmaceutical and Biomedical Analysis|2024Cited by 0